The election of Donald Trump as President of the United States marks a significant shift in global politics, potentially impacting various industries and social movements, including the burgeoning psychedelic research field. As mushroom-based therapies and psychedelics like psilocybin gain momentum in the UK and Europe, many wonder how Trump’s presidency might influence policies, scientific research, […]
Microdosing, the practice of taking tiny, sub-perceptual doses of psychedelics like psilocybin, has gained considerable attention as a potential mental health aid, particularly for issues like depression, anxiety, and PTSD. Unlike recreational use, microdosing aims to deliver therapeutic benefits without producing intense hallucinogenic effects. In the UK and Europe, where mental health awareness is growing, […]